Wendy Chung - Aug 1, 2022 Form 4 Insider Report for Rallybio Corp (RLYB)

Role
Director
Signature
/s/ Michael Greco, Attorney-in-Fact
Stock symbol
RLYB
Transactions as of
Aug 1, 2022
Transactions value $
$0
Form type
4
Date filed
8/3/2022, 05:48 PM
Next filing
Oct 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLYB Option (Right to Buy) Award $0 +26.9K $0.00 26.9K Aug 1, 2022 Common Stock 26.9K $9.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in three equal annual installments beginning on August 1, 2023.